Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Furin cleavage of the SARS-CoV-2 spike is modulated by O -glycosylation

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2109905118Source: DataRank Database

Furin cleavage of the SARS-CoV-2 spike is modulated by O -glycosylation is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0.753. It has been cited 150 times.

N/A

0.753DataRank · unranked

Scored on demand from live citation data

Open Access150 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: hybridTopics (30)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.753

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (9)

Matthew Mann ORCID,Zulfeqhar A. Syed ORCID,Hayley M. Reynolds ORCID,E Tian,N.L. Samara ORCID

Live enrichment

PubMed:34732583 PMC:PMC8617502

HHS | NIH | National Institute of Dental and Craniofacial Research

Grant: Z01-DE-000713

HHS | NIH | National Institute of Dental and Craniofacial Research

Grant: 1-ZIA-DE000739-05

Intramural NIH HHS

Grant: Z01 DE000713

Intramural NIH HHS

Grant: ZIA DE000739

Intramural NIH HHS

Grant: ZIC DE000750

Intramural NIH HHS

Grant: 1 ZIA DE000739

Intramural NIH HHS

Grant: ZIC DE000750-01

National Institutes of Health

Grant: 1Z01DE000713-03

Role of O-glycosylation in Animal Development

National Institutes of Health

Grant: 1ZIADE000739-11

Structure and Function of UDP-GalNAc:polypeptide alpha-GalNAc transferases

National Institutes of Health

Grant: 1ZICDE000750-03

Imaging Core

hybridLicense: CC BY

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2109905118

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2109905118

Unpaywallhttps://doi.org/10.1073/pnas.2109905118

Europe_PMChttps://europepmc.org/articles/PMC8617502

Europe_PMChttps://europepmc.org/articles/PMC8617502?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell LineGiant CellsAnimalsHumansFurinN-AcetylgalactosaminyltransferasesCell FusionGlycosylationSpike Glycoprotein, CoronavirusSARS-CoV-2Polypeptide N-acetylgalactosaminyltransferase

Keywords

GlycosylationspikeFurinO-Covid-19Sars-cov-2Biological SciencesGiant CellsArticleCell LineCell FusionSpike Glycoprotein, CoronavirusPolypeptide N-acetylgalactosaminyltransferaseAnimalsHumansN-Acetylgalactosaminyltransferases

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

10.6084/m9.figshare.20933514.v1figshare

Additional file 1 of The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

10.6084/m9.figshare.20933514figshare

Additional file 1 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599849.v1figshare

Additional file 1 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599849figshare

Additional file 2 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599852.v1figshare

Additional file 2 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599852figshare

Additional file 2 of The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

10.6084/m9.figshare.20933520.v1figshare

Additional file 3 of The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

10.6084/m9.figshare.20933523figshare

Additional file 2 of The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

10.6084/m9.figshare.20933520figshare

Additional file 3 of The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

10.6084/m9.figshare.20933523.v1figshare